Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DNS Cohort Study Aimed at Understanding the Pathophysiology of AD and AD Related Disorders (ADRD)

NCT05153941 is registered in ClinicalTrials.gov with Altoida as lead sponsor.

NCT NCT05153941
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05153941 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DNS Cohort Study Aimed at Understanding the Pathophysiology of AD and AD Related Disorders (ADRD)
Lead sponsor
Altoida
Phase
Observational
Overall status
Active, not recruiting
Start date
January 31, 2022
Completion date
January 31, 2030
Enrollment
3,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease, mild cognitive impairment